We found p32 to be expressed on the surface of differentiated cells, GSCs, and TDEC, and our in vitro studies demonstrated the ability of p32 CAR T cells to specifically recognize and efficiently kill all these populations of glioma cells representing different phenotypic/differentiation states. This evidence concerns the gene CD8A and glioma.